Regulus Therapeutics LLC, a joint venture between Isis Pharmaceuticals Inc. and Cambridge, Mass.-based Alnylam Pharmaceuticals Inc. | San Diego Business Journal (December, 2007)

We have detected that your web browser does not have JavaScript enabled.

To view Goliath's company profiles, news and business information, please enable JavaScript now.

Regulus Therapeutics LLC, a joint venture between Isis Pharmaceuticals Inc. and Cambridge, Mass.-based Alnylam Pharmaceuticals Inc.(HEALTH CARE AND BIOTECH)(Kleanthis Xanthopoulos appointed vice president and CEO)
Publication Date: 17-DEC-07
Publication Title: San Diego Business Journal
Format: Online
Company: Isis Pharmaceuticals Inc.~Joint ventures Alnylam Pharmaceuticals Inc.~Joint ventures
Author: Wiedemann, Liz

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

Over 5 million business articles
Hundreds of the most trusted magazines, newswires, and journals (see list)
Premium business information that is timely and relevant
Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More Terms and Conditions

Description

Regulus Therapeutics LLC, a joint venture between...

More articles from San Diego Business Journal
Jesse Rodriguez has been promoted to wine director for The Grand Del M..., December 17, 2007
Willis Allen Real Estate has added another agent to its Realtor team.(..., December 17, 2007

Looking for additional articles?
Click here to search our database of over 3 million articles.